Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

Clinical trial NCT00833079 · COMPLETED

Trial details

NCT number: NCT00833079
Sponsor: Sun Pharmaceutical Industries, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2008-10-01
Primary completion: 2010-02-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.